Eukaryotic mRNA decay
Team Leader : Bertrand SERAPHIN
Department : Executive management
SUBGROUP LEADER
While the main mRNA decay pathway involves the 5’ to 3’ degradation of the mRNA body, 3’ to 5’ exonucleolytic mRNA trimming has been shown to play a major role for the elimination of defective, poorly translatable transcripts. Factors involved in the latter pathway are altered in a rare human genetic disease, underlining its importance. In this context, we are testing the role of these factors in pathological conditions. Moreover, we have identified new factors associated with 3’-5’ mRNA decay and are actively pursuing their characterization.
Article in a journal
Enzymes ; Volume: 41 ; Page: 117-149
Article in a journal
Nature Structural and Molecular Biology ; Volume: 23 ; Page: 982-986
Article in a journal
Molecular Cell ; Volume: 63 ; Page: 927-38
Article in a journal
Nature Structural and Molecular Biology ; Page: 794-802
Article in a journal
Nature Communications ; Volume: 7
Article in a journal
Nucleic Acids Research ; Volume: 44 ; Page: 437-448
Article in a journal
Human Molecular Genetics ; Volume: 24 ; Page: 3163-3171
Article in a journal
Nucleic Acids Research ; Volume: 43 ; Page: 482-492
Article in a journal
FEBS Journal ; Volume: 282 ; Page: 819-833
Article in a journal
PLoS ONE ; Volume: 9 ; Page: e96828
Page 2 of 5